Shinpoong Pharm shares drop on regulator probe

2023. 9. 22. 14:00
글자크기 설정 파란원을 좌우로 움직이시면 글자크기가 변경 됩니다.

이 글자크기로 변경됩니다.

(예시) 가장 빠른 뉴스가 있고 다양한 정보, 쌍방향 소통이 숨쉬는 다음뉴스를 만나보세요. 다음뉴스는 국내외 주요이슈와 실시간 속보, 문화생활 및 다양한 분야의 뉴스를 입체적으로 전달하고 있습니다.

[Courtesy of Shinpoong Pharmaceutical]
Shinpoong Pharmaceutical shares fell Friday morning as the Financial Services Commission (FSC) has launched an investigation into allegations that employees had traded shares using undisclosed information.

As of 9:06 a.m. local time, Shinpoong Pharm was trading at 15,230 won ($11.4), down 3.67 percent from the previous session.

The stock price saw a significant drop shortly after the market opened, falling to as low as 14,800 won and struggled to hit the 15,000 won mark.

According to sources on Friday, the FSC conducted an on-site investigation at Shinpoong Pharm’s headquarters in Gangnam-gu, Seoul, on Thursday.

The company’s stock price, which was around 6,000 won in February 2020, jumped to 214,000 won seven months later over the news that it was developing a coronavirus cure. But subsequently, due to negative announcements related to clinical trial results, the stock price dropped sharply.

The FSC is currently investigating whether company employees engaged in stock trading using undisclosed information during this period. The use of such undisclosed information in stock trading can result in fines up to 3 to 5 times the profit or loss avoided, in addition to a prison sentence of more than a year.

Copyright © 매일경제 & 무단 전재, 재배포 및 AI학습 이용 금지

이 기사에 대해 어떻게 생각하시나요?